Search research articles
Contact Us
Filters
Showing results (151-160 of 383) with videos related to
Page
of 39
Sort By:
Cancer
|
November 26, 2008
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803)
David L Grinblatt, Daohai Yu, Vera Hars, et al.
The Journal of Biological Chemistry
|
July 13, 2010
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism
Margret S Fernandes, Mamatha M Reddy, Nicole J Croteau, et al.
Pediatric Blood & Cancer
|
March 2, 2012
FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group
Matthew A Kutny, Barry K Moser, Kristina Laumann, et al.
Cancer
|
May 5, 2016
Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies
Hagop M Kantarjian, Anthony S Stein, Ralf C Bargou, et al.
European Journal of Clinical Pharmacology
|
December 31, 2011
Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase
Richard A Larson, Ophelia Q P Yin, Andreas Hochhaus, et al.
Experimental Hematology & Oncology
|
January 10, 2019
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Yun Fan, Andrew S Artz, Koen van Besien, et al.
Haematologica
|
May 13, 2014
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients
Lori S Muffly, Masha Kocherginsky, Wendy Stock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2022
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention
Andrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2003
Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study
Elizabeth A Hahn, G Alastair Glendenning, Mark V Sorensen, et al.
Cancer
|
October 10, 2013
Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials
William G Woods, Anna R K Franklin, Todd A Alonzo, et al.
Page
of 39
Search research articles
Search
Showing results (151-160 of 383) with videos related to
Sort By:
Page
of 39
Cancer
|
November 26, 2008
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803)
David L Grinblatt, Daohai Yu, Vera Hars, et al.
The Journal of Biological Chemistry
|
July 13, 2010
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism
Margret S Fernandes, Mamatha M Reddy, Nicole J Croteau, et al.
Pediatric Blood & Cancer
|
March 2, 2012
FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group
Matthew A Kutny, Barry K Moser, Kristina Laumann, et al.
Cancer
|
May 5, 2016
Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies
Hagop M Kantarjian, Anthony S Stein, Ralf C Bargou, et al.
European Journal of Clinical Pharmacology
|
December 31, 2011
Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase
Richard A Larson, Ophelia Q P Yin, Andreas Hochhaus, et al.
Experimental Hematology & Oncology
|
January 10, 2019
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Yun Fan, Andrew S Artz, Koen van Besien, et al.
Haematologica
|
May 13, 2014
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients
Lori S Muffly, Masha Kocherginsky, Wendy Stock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2022
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention
Andrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2003
Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study
Elizabeth A Hahn, G Alastair Glendenning, Mark V Sorensen, et al.
Cancer
|
October 10, 2013
Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials
William G Woods, Anna R K Franklin, Todd A Alonzo, et al.
Page
of 39